RSS   Newsletter   Contact   Advertise with us
Post Online Media

Ipsen appoints Alexandre Lebeaut as EVP

Alexandre LebeautIpsen, a pharmaceutical company, announced the appointment of Alexandre Lebeaut as executive vice-president, R&D, and chief scientific officer.

Before joining Ipsen, Dr. Lebeaut held several global leadership positions in Clinical Development and Medical Affairs with biopharmaceutical companies including Axcan Pharmaceuticals, Sanofi, Novartis and Schering Plough Research Institute.

READ MORE Ipsen: Marc de Garidel new chairman and CEO

Dr. Lebeaut earned his M.D. from Paris Diderot University and specialized in Pediatrics from Paris Descartes University.


More inside POST

We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy